Riskpilot← Back to searchSign inGet full accessMerelymedic AB
ABActiveOrg 5592743610Mistlursvägen 1 CGeneral medical practice activities · NACE 8621Est. 20200 employees
Revenue 2025
SEK 48K
-58% vs 2024
EBITDA margin
-36.2%
-384% vs 2024
Equity ratio
56.5%
Financial strength
Net profit 2025
SEK 86K
+36% vs 2024
| Revenue | SEK 48K | -58% |
| EBITDA | SEK -18K | -384% |
| Net profit | SEK 86K | +36% |
| Total assets | SEK 204K | -19% |
| Equity | SEK 115K | +6% |
| Employees | 0 | — |
Legal name
Merelymedic AB
Org number
5592743610
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 oktober 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva hälsovård och sjukvård, förebygga, diagnosticera, bedöma, utreda och behandla sjukdomar och skador samt därmed förenlig verksamhet. Bedriva friskvård och därmed förenlig verksamhet.
Address
Mistlursvägen 1 C
Email
sandra_gustaf@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 128 | 98 | 117 | 115 | 48 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 6 | 21 | 51 | 6 | −18 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 6 | 21 | 51 | 6 | −18 |
| Net financials | — | — | 58 | 76 | 128 |
| Profit before tax | 6 | 15 | 109 | 82 | 110 |
| Tax | −1 | −4 | −23 | −18 | −24 |
| Net profit | 5 | 11 | 85 | 64 | 86 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 65 | 83 | 193 | 251 | 204 |
| Equity | 30 | 40 | 126 | 109 | 115 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 35 | 36 | 61 | 135 | 82 |
| Total debt | 35 | 36 | 61 | 135 | 82 |
EBITDA margin
-36.2%
This company
15.8%
Market median
-329% vs market
20212025
Equity ratio
56.5%
This company
38.2%
Market median
+48% vs market
20212025
Return on equity
74.7%
This company
18.4%
Market median
+306% vs market
20212025
Net profit margin
177.7%
This company
8.1%
Market median
+2094% vs market
20212025
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20212025
Debt / equity
0.77×
This company
0.62×
Market median
+24% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Merelymedic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sandra Elisabeth Lindqvist | Board of Directors | 0 companies |
| David Michael Gustafsson | Deputy Board Member | 0 companies |